Heidelberg, Germany, May 28, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate […]
GAITHERSBURG, Md., May 27, 2020 (GLOBE NEWSWIRE) — Viela Bio, Inc. (Nasdaq:VIE), a clinical-stage biotechnology company pioneering treatments for autoimmune […]
RESEARCH TRIANGLE PARK, N.C., May 27, 2020 (GLOBE NEWSWIRE) — Liquidia Technologies, Inc. (Nasdaq: LQDA), a late-stage clinical biopharmaceutical company focused […]